The 60-Second Answer:
GSM is a group of vaginal, vulvar, sexual, and urinary changes caused mainly by falling estrogen during menopause. Common symptoms include dryness, itching, burning, painful intercourse, frequent urination, and repeated UTIs. It usually does not disappear without care, but it is highly treatable. Moisturizers, lubricants, pelvic therapy, and prescription treatments can greatly relieve symptoms and improve tissue health over time.
GSM Is Treatable, Not Permanently Cured
Genitourinary syndrome of menopause, or GSM, describes genital, sexual, and urinary changes caused primarily by declining estrogen during the menopause transition. Experts introduced this term as new terminology for vulvovaginal atrophy because it includes changes to the vagina, vulva, urethra, and bladder, not just vaginal atrophy.[1]
Unlike hot flashes and other vasomotor symptoms, GSM commonly persists or progresses without treatment. However, that does not mean a woman must accept vaginal discomfort as an unavoidable part of her Second Spring.
Effective management and treatment can improve vaginal dryness, vaginal elasticity, painful intercourse, burning, and urinary symptoms. Continued therapy is often needed to maintain the response to treatment.
Estrogen Loss Changes Vaginal Tissue
Estrogen binds to hormone receptors throughout the vulva, vaginal wall, urethra, bladder, and pelvic floor. When estrogen declines, the vaginal lining contains less glycogen, fewer protective lactobacilli, and less moisture. Vaginal pH may rise from its usual acidic range, contributing to microbiome changes and vulnerability to irritation or urinary tract infections.
The vaginal mucosa can become thinner and paler, while vaginal secretions, blood flow, and collagen decline. Clinicians may observe vaginal pallor, reduced vaginal elasticity, loss of vaginal rugae, narrowing of the vaginal opening, or shortening of the vaginal canal.
Progesterone also falls during menopause, but estrogen deficiency is the principal hormonal driver of GSM. Pain can trigger protective tightening of the pelvic floor muscles and nervous system regulation that anticipates discomfort. This helps explain why tissue treatment alone may not fully resolve painful intercourse in every woman.
GSM Symptoms Affect More Than Sex
The symptoms of genitourinary syndrome vary significantly. Some women with GSM experience only one bothersome symptom, while others develop several genitourinary symptoms.
Common signs and symptoms include:
- Vaginal dryness, burning, itching, or irritation
- Vaginal dryness and dyspareunia
- Pain, tearing, or spotting during sexual activity
- Reduced lubrication or vaginal discomfort
- Urinary urgency, frequency, burning, or leakage
- Recurrent urinary tract infection
- Changes in vaginal discharge
Unusual bleeding, persistent discharge, sores, or pelvic pain require medical assessment because infection, skin disorders, and cancer can resemble vaginal atrophy symptoms.
Treatment Options Offer Different Benefits
Diagnosis and treatment should be based on symptoms, examination findings, medical history, and personal priorities. Hormone testing and the vaginal maturation index are rarely required for routine diagnosis.
| Treatment Option | Best-Supported Use | Typical Use | Important Limitation |
|---|---|---|---|
| Vaginal moisturizer | Ongoing mild dryness | Every 2 to 3 days | Relief requires consistent use |
| Vaginal lubricants | Friction during sexual activity | Immediately before activity | Provides temporary comfort |
| Low-dose vaginal estrogen | Moderate or persistent GSM symptoms | Product-specific maintenance schedule | Requires clinician guidance |
| Vaginal DHEA | Moderate to severe painful intercourse | Once daily, as prescribed | Hormonal precursor requiring review |
| Ospemifene | Treatment of dyspareunia | Oral daily prescription | Has systemic effects and contraindications |
| Pelvic floor therapy | Guarding, tension, or persistent pain | Individualized sessions | Does not directly restore estrogen |
The 2025 AUA/SUFU/AUGS guideline supports vaginal lubricants and moisturizers and recommends local low-dose vaginal estrogen for dryness, irritation, dyspareunia, and recurrent urinary tract infections. Evidence does not currently support vaginal laser or radiofrequency as established treatment for GSM.[2]
Nonhormonal Management Can Ease GSM
Women seeking treatment of vaginal atrophy without hormones can begin with a vaginal moisturizer rather than a standard body lotion. Hyaluronic acid or polycarbophil-based products may help retain moisture. Use a water-based or silicone-based lubricant before sexual activity, with silicone formulas generally lasting longer.
Regular, comfortable vaginal stimulation may support blood flow and flexibility, but sexual activity is never medically required. Vaginal dilators and pelvic floor physical therapy can help when the vaginal opening feels tight or the nervous system has learned to brace against pain.
Avoid fragranced washes, vaginal douches, and products that sting. Evidence for probiotics or supplements as treatment for GSM remains limited.
Vaginal Estrogen Provides Local Relief
When nonhormonal care is insufficient, vaginal estrogen products include a vaginal cream, vaginal tablet, insert, or vaginal ring. These treatments deliver low doses to vaginal tissue and generally produce much less systemic exposure than systemic hormone therapy.
Vaginal DHEA and oral ospemifene are additional prescription options for treatment of dyspareunia. Women with breast cancer should begin with nonhormonal methods and discuss persistent symptoms with their gynecologist and oncology team. ACOG states that low-dose vaginal estrogen may be considered after shared decision-making when first-line measures fail, including for some women taking tamoxifen.[3]
A Practical GSM Relief Protocol
- Record dryness, burning, pain, urinary symptoms, and triggers for two weeks.
- Apply a vaginal moisturizer according to its label, commonly two or three times weekly.
- Use sufficient water-based or silicone lubricant immediately before sexual activity.
- Stop penetration if pain becomes sharp. Ask about pelvic floor physical therapy if tightening or pain continues.
- Reassess after 8 to 12 weeks. Seek prescription treatment if relief is inadequate.
- Report bleeding after menopause, blood in urine, sores, unusual vaginal discharge, or repeated infection promptly.
Product dosing varies, so follow the label or prescription rather than improvising treatment inside the vaginal vault.
The 2025 Guideline Adds Expert Context
A useful expert angle is to treat GSM as a connected tissue and pain condition, not merely dryness. The 2025 multidisciplinary guideline emphasizes symptom-based diagnosis, shared decision-making, and reassessment.[2] For a Wise Woman experiencing persistent pain, combining tissue support with pelvic floor and nervous system care may provide more complete relief than repeatedly changing lubricants.
Frequently Asked Questions
What Are The First Signs Of GSM And Can It Be Cured Without Hormones?
Early symptoms of GSM often include vaginal dryness, burning, irritation, reduced lubrication, or urinary urgency. Mild symptoms may improve with vaginal lubricants and moisturizers. Nonhormonal care controls symptoms but does not restore declining estrogen.
Why Does GSM Cause Urinary Urgency And Painful Intercourse?
Low estrogen thins and dries the vaginal and urethral tissues while reducing flexibility and lubrication. Friction can then cause painful intercourse, while changes in the genitourinary tract contribute to urgency and recurrent urinary tract infections. Pelvic floor tightening may intensify both problems.
Is GSM Permanent Or Manageable With Lifestyle Changes?
The hormonal tendency behind GSM is usually chronic, but symptoms are highly manageable. Lifestyle measures can reduce irritation and support comfort, especially when symptoms are mild. Persistent or severe symptoms may require prescription treatment for GSM.
How Do I Discuss GSM Symptoms Without Embarrassment?
Tell your clinician directly: “Since menopause, I have noticed vaginal or urinary changes affecting my comfort.” Mention pain, dryness, urinary tract symptoms, and how they affect daily life or intimacy. Clinicians routinely evaluate these concerns, even though many women feel uncomfortable discussing symptoms.
Continue Your Journey
Explore our complete guide to How do I manage painful intercourse and vaginal atrophy without hormones? for practical nonhormonal strategies, pelvic floor support, and questions to discuss with your clinician.
References
- Portman DJ, Gass MLS. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy. Journal of Sexual Medicine. 2014;11(12):2865-2872. PubMed
- Kaufman MR, Ackerman LA, Amin KA, et al. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. Journal of Urology. 2025. doi:10.1097/JU.0000000000004589. Guideline
- American College of Obstetricians and Gynecologists. Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-Dependent Breast Cancer. Obstetrics & Gynecology. 2021;138:950-960. ACOG Clinical Consensus
- The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement. Menopause. 2020;27(9):976-992. PubMed
